Alerts

Key Sun Laboratories Pty Ltd is recalling four batches of lozenges due to the risk of a small metal wire being present in the lozenge.

TGA reviewed the TouchBio Chlamydia & Gonorrhoea self-test (for females) to verify its performance.

We are advising consumers that sexual enhancement products labelled as ‘honey’ may pose a serious risk to your health and should not be taken.

Cases of liver injury associated with herbal preparations containing Withania somnifera, commonly known as Ashwagandha, continue to be reported both in Australia and internationally.

We are advising that Eagle Research Lab branded selective androgen receptor modulators (SARMs) pose a serious risk to your health and should not be taken.

Aidacare Pty Ltd has updated the Instructions for Use (IFU) for the Aspire A205 Aluminium Patient Lifter. The IFU has been enhanced to strengthen existing instructions around correct and incorrect sling attachment methods and pre-use checks.

We are advising consumers that ITCHA SSS capsules, marketed for weight management, have been found to contain oxedrine, an undisclosed prescription-only medicine.

We are advising consumers that Grakcu capsules may pose a serious risk to your health and should not be taken.

The Therapeutic Goods Administration (TGA) is advising consumers that several sexual enhancement products have been found to contain undeclared ingredients and may pose a serious risk to your health.

Supply constraints will continue until 31 January 2027.

We are advising consumers that ‘Pharmatech’ branded MK-677 capsules (containing ibutamoren) may pose a serious risk to your health and should not be taken.

Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare, is recalling the below products due to the potential presence of a glass fragment within the bottle (not within the tablets).

Mindray Medical Australia Pty Ltd is conducting a product correction for the BeneHeart D1 Automated External Defibrillator. The operator’s manual is being updated for the procedure of switching patient types.

Progressive discontinuation of all products will start with the 600 mg strength from 30 November 2026.

AA-Med Pty Ltd is recalling two lots of Dexcom G7 sensors. These lots were identified for disposal and destruction in the USA due to incomplete sterilisation and deployment failure during testing.

We are warning consumers about the risks of importing and using unapproved peptide products that are promoted online.

The acute national shortages of IV fluids have resolved.

Serious Scarcity Substitution Instrument (SSSI) has lapsed and product is available.

Information about the cyclophosphamide and ifosfamide injection shortages.

The overall supply of methylphenidate modified-release products continues to improve and stabilise.

We are advising consumers that Artri Ajo King tablets may pose a serious risk to your health and should not be taken.

GlaxoSmithKline (GSK) Australia Pty Ltd is issuing a product correction for certain batches of their Flixotide and Pavtide Accuhalers as a small number of Accuhalers may not automatically reload the next dose.

We are concerned about the rise in the import, supply, compounding and advertising of unapproved peptide products and the potential safety risks associated with these goods.

Boston Scientific is conducting a Product correction and Product alert for ACCOLADE and VISIONIST pacemakers.

AC Newco Pty Ltd (Advanced Cosmeceuticals), on behalf of Medik8, is recalling all unexpired batches of Medik8 Physical Sunscreen SPF50+ 60mL, 60mL Professional, & 15mL due to the product being unlikely to meet its labelled Sun Protection Factor (SPF) rating.